a,3-二甲基-5-异噁唑甲醇 | 71502-43-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: a,3-二甲基-5-异噁唑甲醇
• 英文名称: (3-methyl-5-isoxazolyl)-1-ethanol
• 英文别名: 1-(3-methylisoxazol-5-yl)ethanol；1-(3-methyl-isoxazol-5-yl)-ethanol；1-(3-methyliosoxazol-5-yl)ethanol；5-(1-Hydroxyaethyl)-3-methyl-1,2-oxazol；1-(3-methyl-1,2-oxazol-5-yl)ethanol
• CAS: 71502-43-7
• 化学式: C₆H₉NO₂
• 分子量: 127.143
• InChiKey: QLOCZOGQZFCJAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  a,3-二甲基-5-异噁唑甲醇 在 palladium on activated charcoal chromium(VI) oxide 、 盐酸 、 硫酸 、 氢气 作用下， 以 乙醚 、 水 、 丙酮 为溶剂， 反应 1.5h， 生成 2-(4-氟苯基)-2,5-二甲基呋喃-3-酮
  参考文献：
  名称：

  Synthesis and antiulcer activity of novel 5-(2-ethenyl substituted)-3(2H)-furanones

  摘要：

  In order to investigate new antiulcer agents, spizofurone 1 (AG-629) was fragmented and reassembled to generate 5-phenyl-2,2-dimethyl-3(2H)-furanone (bullatenone, 2). Because of the antiulcer activity of 2,5-phenyl-substituted 2,2-dimethyl-3(2H)-furanones (3-6) were made and shown to have poor activity. Insertion of an ethenyl link between the furanone and phenyl rings gave 5-(2-phenylethenyl)-2,2-dimethyl-3(2H)-furanone (7). This compound had better activity than 2. Compounds 8-41 were synthesized to evaluate the SAR in 5-(2-ethenyl substituted)-3(2H)-furanones. Electron-withdrawing substituents on the aromatic ring (8, 10, 19, and 20) gave 2-3-fold higher activity. Further increases in the activity were found when the phenyl ring was replaced by heterocyclic nuclei. Compounds that contained a thiophene (29), pyridine (24-26), or quinoline ring (32) had the best activity. Replacement of the methyl group on the furanone ring with a phenyl (34) or p-fluorophenyl (40) substituent in the 2-pyridine series gave compounds with activity that ranked with the best obtained in this study. The best compounds from the above SAR studies were evaluated in the ethanol-necrosis model for duration of cytoprotection action. Compounds 19, 24, and 29, which had the best duration of action, were tested with AG-629 in the acidified aspirin and indomethacin-induced lesion models. Only compound 24 had equivalent activity with AG-629 in both models.

  DOI：

  10.1021/jm00085a003
• 作为产物：
  描述：

  3-甲基-5-乙酰基异恶唑 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 生成 a,3-二甲基-5-异噁唑甲醇
  参考文献：
  名称：

  New 5-(2-ethenylsubstituted)-3(2H)-furanones with in vitro antiproliferative activity

  摘要：

  A convenient route to new 3(2H)-furanones is described through hydrogenolysis and subsequent acidic hydrolysis of isoxazoles. The antiproliferative activity of title compounds were evaluated against leukemia-, carcinoma-, neuroblastoma-, and sarcoma-derived human cell lines in comparison to the natural compound geiparvarin. The structure activity relationship indicated that the maximum in vitro antiproliferative activity correlates with the presence of a heterocyclic ring on the ethenyl moiety. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(03)00776-2

文献信息

• [EN] ALKYNYL ALCOHOLS AS KINASE INHIBITORS<br/>[FR] ALCOOLS D'ALCYNYLE UTILISÉS COMME INHIBITEURS DE KINASES
  申请人：AMGEN INC

  公开号：WO2009158011A1

  公开（公告）日：2009-12-30

  Selected compounds are effective for prophylaxis and treatment of inflammation and inflammatory disorders, such as NIK-mediated disorders. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, inflammation and the like.

  选定的化合物对预防和治疗炎症和炎症性疾病，如NIK介导的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药及其药用可接受的盐，以及用于预防和治疗涉及炎症等疾病和其他疾病或病症的药物组合物和方法。
• [EN] SULFOXIMINE SUBSTITUTED QUINAZOLINES AND THEIR USE AS MNK1 AND/OR MNK2 KINASE INHIBITORS<br/>[FR] QUINAZOLINES SUBSTITUÉES PAR UNE SULFOXIMINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE KINASE MNK1 ET/OU MNK2
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2014206922A1

  公开（公告）日：2014-12-31

  This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I) wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1 a or MNK1 b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1 a or MNK1 b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.

  本发明涉及新型.sulfoximine取代喹唑啉衍生物，其通式为(I)，其中Ar，R1和R2如说明和权利要求中所定义，以及其作为MNK1(MNK1α或MNK1β)和/或MNK2(MNK2α或MNK2β)激酶抑制剂的应用，包含该制剂的药物组合物，以及使用该制剂作为治疗或改善MNK1(MNK1α或MNK1β)和/或MNK2(MNK2α或MNK2β)介导的疾病的制剂的方法。
• SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS
  申请人：BLUM Andreas

  公开号：US20150005278A1

  公开（公告）日：2015-01-01

  This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R 1 and R 2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.

  本发明涉及一类新型的.sulfoximine取代喹唑啉衍生物，其通式为I，其中Ar，R1和R2定义如说明和权利要求中所述，以及它们作为MNK1 (MNK1a或MNK1b)和/或MNK2 (MNK2a或MNK2b)激酶抑制剂的应用，包含同一的药物组合物，以及使用它们作为治疗或改善MNK1 (MNK1a或MNK1b)和/或MNK2 (MNK2a或MNK2b)介导的疾病的剂的方法。
• Anti-ulcer 5-(2-substituted ethenyl)-3-(2H)-furanones
  申请人：American Home Products Corporation

  公开号：US04966905A1

  公开（公告）日：1990-10-30

  A compound of the formula: ##STR1## in which R is alkyl, phenyl or halophenyl; R.sup.2 is substituted phenyl having from 1 to 3 substituents selected from halo, alkyl, alkylthio, alkylsulfonyl, cyano, trifluoromethyl, or R.sup.2 is pyridinyl, pyrazinyl, quinolinyl, N-alkylpyrrolyl, thienyl, benzothienyl, or furyl; and n is 1 or 2, are cytoprotective anti-ulcer agents.

  化合物的公式为：##STR1## 其中 R 是烷基，苯基或卤代苯基；R.sup.2 是被取代的苯基，其有 1 到 3 个取代基，选自卤素，烷基，硫代烷基，磺酰基烷基，氰基，三氟甲基，或 R.sup.2 是吡啶基，吡嗪基，喹啉基，N-烷基吡咯基，噻吩基，苯并噻吩基或呋喃基；n 是 1 或 2，是细胞保护性抗溃疡剂。
• Anti-ulcer 5-(2-substituted ethenyl)-3(2H)-furanones
  申请人：American Home Products Corporation

  公开号：US05001126A1

  公开（公告）日：1991-03-19

  A compound of the formula: ##STR1## in which R is alkyl, phenyl or halophenyl; R.sup.2 is substituted phenyl having from 1 to 3 substituents selected from halo, alkyl, alkylthio, alkylsulfonyl, cyano, trifluoromethyl, or R.sup.2 is pyridinyl, pyrazinyl, quinolinyl, N-alkylpyrrolyl, thienyl, benzothienyl, or furyl; and n is 1 or 2, are cytoprotective anti-ulcer agents.

  化合物的公式为：##STR1## 其中R是烷基，苯基或卤代苯基; R.sup.2是取代苯基，其取代基从卤，烷基，烷基硫醇，烷基磺酰，氰，三氟甲基中选择1到3个，或R.sup.2是吡啶基，吡嗪基，喹啉基，N-烷基吡咯基，噻吩基，苯并噻吩基或呋喃基; n为1或2，是细胞保护的抗溃疡剂。